Universe Pharmaceuticals Statistics Share Statistics Universe Pharmaceuticals has 563.34K
shares outstanding. The number of shares has increased by 159.57%
in one year.
Shares Outstanding 563.34K Shares Change (YoY) 159.57% Shares Change (QoQ) 160.17% Owned by Institutions (%) 0.47% Shares Floating 559.87K Failed to Deliver (FTD) Shares 406 FTD / Avg. Volume 0.44%
Short Selling Information The latest short interest is 30.3K, so 0.2% of the outstanding
shares have been sold short.
Short Interest 30.3K Short % of Shares Out 0.2% Short % of Float 0.2% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.1 and the forward
PE ratio is null.
Universe Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.1 Forward PE n/a PS Ratio 0.04 Forward PS n/a PB Ratio 0.02 P/FCF Ratio -0.09 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Universe Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.54,
with a Debt / Equity ratio of 0.18.
Current Ratio 2.54 Quick Ratio 2.46 Debt / Equity 0.18 Debt / EBITDA -1.09 Debt / FCF -0.81 Interest Coverage -28.83
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $102.33K Profits Per Employee $-38.79K Employee Count 225 Asset Turnover 0.34 Inventory Turnover 9.76
Taxes Income Tax 606.7K Effective Tax Rate -7.47%
Stock Price Statistics The stock price has increased by -99.84% in the
last 52 weeks. The beta is 1.44, so Universe Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.44 52-Week Price Change -99.84% 50-Day Moving Average 3.88 200-Day Moving Average 29.75 Relative Strength Index (RSI) 46.41 Average Volume (20 Days) 92,719
Income Statement In the last 12 months, Universe Pharmaceuticals had revenue of 23.02M
and earned -8.73M
in profits. Earnings per share was -1436.12.
Revenue 23.02M Gross Profit 6.07M Operating Income -8.02M Net Income -8.73M EBITDA -7.36M EBIT -7.84M Earnings Per Share (EPS) -1436.12
Full Income Statement Balance Sheet The company has 29.5M in cash and 7.99M in
debt, giving a net cash position of 21.5M.
Cash & Cash Equivalents 29.5M Total Debt 7.99M Net Cash 21.5M Retained Earnings -10.17M Total Assets 80.67M Working Capital 41.61M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.51M
and capital expenditures -363.09K, giving a free cash flow of -9.87M.
Operating Cash Flow -9.51M Capital Expenditures -363.09K Free Cash Flow -9.87M FCF Per Share -1624.12
Full Cash Flow Statement Margins Gross margin is 26.37%, with operating and profit margins of -34.83% and -37.9%.
Gross Margin 26.37% Operating Margin -34.83% Pretax Margin -35.27% Profit Margin -37.9% EBITDA Margin -31.95% EBIT Margin -34.83% FCF Margin -42.87%
Dividends & Yields UPC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for UPC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Mar 24, 2025. It was a
backward
split with a ratio of 1:40.
Last Split Date Mar 24, 2025 Split Type backward Split Ratio 1:40
Scores Altman Z-Score 0.39 Piotroski F-Score 4
